Literature DB >> 18609101

Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.

Elena Bargagli1, Nicola Bianchi, Maria Margollicci, Carmela Olivieri, Alice Luddi, Giuseppe Coviello, Salvatore Grosso, Paola Rottoli.   

Abstract

BACKGROUND: Sarcoidosis is a multisystemic granulomatous disease with an unpredictable clinical course characterized by accumulation of activated proliferating T lymphocytes and mononuclear phagocytes in affected organs. AIMS AND METHODS: The aims of this study were to describe the clinical, radiological and immunological features of a population of sarcoidosis patients followed at the Sarcoidosis Regional Centre in Siena and to analyse chitotriosidase and sIL-2R concentrations in serum of these patients in order to understand their potential as disease markers.
RESULTS: Chitotriosidase and sIL-2R concentrations in serum of sarcoidosis patients were found to be significantly higher than in healthy controls (p<0.01) and a positive correlation between the two markers was documented for the first time. Moreover, chitotriosidase and sIL-2R were expressed differently in different radiographic stages of the disease.
CONCLUSION: Chitotriosidase and sIL-2R are two markers of sarcoidosis of different origin, the values of which show a correlation in these patients; they are easily detectable in serum and could be useful clinical markers of progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18609101     DOI: 10.1080/00365510701854975

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  16 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Role of chitotriosidase (chitinase 1) under normal and disease conditions.

Authors:  Manasa Kanneganti; Alan Kamba; Emiko Mizoguchi
Journal:  J Epithel Biol Pharmacol       Date:  2012

4.  [Bilateral recurrent blurred vision associated with halos around sources of light and headache].

Authors:  D Völcker; T Reinhard; T Ness
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

5.  Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Authors:  Alexandra N Bickett; Elyse E Lower; Robert P Baughman
Journal:  Chest       Date:  2018-05-17       Impact factor: 9.410

6.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

7.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

8.  Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis.

Authors:  Masaru Ando; Akihiko Goto; Yukiko Takeno; Mari Yamasue; Kosaku Komiya; Kenji Umeki; Shin-Ichi Nureki; Eishi Miyazaki; Jun-Ichi Kadota
Journal:  Clin Rheumatol       Date:  2018-06-23       Impact factor: 2.980

9.  Serum B cell activating factor (BAFF) and sarcoidosis activity.

Authors:  Kamila Hashemzadeh; Maryam Fatemipour; Seyede Zahra Mirfeizi; Mohammadhasan Jokar; Zhaleh Shariati Sarabi; Mohammad-Reza Hatef Fard; Houshang Rafatpanah; Mandana Khodashahi
Journal:  Arch Rheumatol       Date:  2020-09-11       Impact factor: 1.472

10.  Clinical phenotyping in sarcoidosis management.

Authors:  Giuseppe Domenico Rana; Miriana d'Alessandro; Luigi Rizzi; Laura Bergantini; Paolo Cameli; Alfredo Vozza; Piersante Sestini; Patrizia Suppressa; Elena Bargagli
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.